| Literature DB >> 30286099 |
Sruthi Arepalli1, Sunil K Srivastava1,2, Ming Hu1,2,3, Peter M Kaiser2, Neeley Dukles1,2, Jamie L Reese1,2, Justis P Ehlers1,2.
Abstract
PURPOSE: Ellipsoid zone (EZ) and outer retinal integrity are strongly linked to visual prognosis, but quantitative normative data is lacking. This study evaluates the EZ, outer retina, and inner retina in eyes without macular disease across a wide age spectrum.Entities:
Mesh:
Year: 2018 PMID: 30286099 PMCID: PMC6171834 DOI: 10.1371/journal.pone.0203324
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Segmentation map of macular OCT in a patient without macular pathology.
(A) Segmentation of inner and outer retinal layers, at the inner limiting membrane (ILM, blue), outer limiting membrane (OLM, green), ellipsoid zone (EZ, yellow), and retinal pigment epithelium (RPE, red). (B) SD-OCT B scan. (C) EZ-RPE thickness map. (D) ILM-RPE thickness map.
Fig 2Comparison of EZ loss.
(A) En-face map of the EZ layer with minimal loss, as shown by the majority of the green, from a patient included in this normative EZ study. (B) En-face map with moderate EZ loss, with more central blue, from a patient with Stargardt disease. (C) Severe loss, as shown by the expansive central blue areas, also from a patient with Stargardt disease.
Assessment of inner and outer retinal layer metrics on the cirrus HD-OCT platform in normal eyes, demographic features.
| Feature | All patients (n = 167) | |
|---|---|---|
| Age (years) Mean (median, range) | 49.7 years (55, 10–84 years) | |
| Gender | Male | 66 (39.5%) |
| Female | 101 (60.5%) | |
| Spherical Equivalent (diopters) Mean (median, range) | -0.48 (0.0, -5.63 to 4.3) | |
| BCVA | 20/15 | 5 (7.5%) |
| 20/20 | 126 (71.6%) | |
| 20/25 | 23 (13.0%) | |
| 20/30 | 11 (6.3%) | |
| 20/40 | 2 (1.2%) | |
| Lens Status | Phakic | 146 (87.4%) |
| Pseudophakic | 21 (12.6%) | |
| Laterality | Right | 87 (52.1%) |
| Left | 80 (47.9%) | |
| Reason for OCT | Hydroxychloroquine use | 39 (23.4%) |
| Uveitis/endophthalmitis, contralateral eye | 24 (12.2%) | |
| Baseline (initial visit) | 19 (11.3%) | |
| Retinal vein occlusion, contralateral eye | 17 (10.2%) | |
| CSR, contralateral eye | 14 (8.4%) | |
| Macular hole, contralateral eye | 14 (8.4%) | |
| Retinal detachment or retinal tear, contralateral eye | 12 (7.2%) | |
| Cataract evaluation, contralateral eye | 11 (8.4%) | |
| Macular edema, contralateral eye | 9 (5.4%) | |
| ERM, contralateral eye | 8 (4.8%) | |
| History of diabetes | 4 (2.4%) | |
| AMD, contralateral eye | 2 (1.2%) | |
| Coats disease, contralateral eye | 1 (0.6%) | |
Assessment of inner and outer retinal layer metrics on the cirrus HD-OCT platform in normal eyes, metrics in entire cohort and sex breakdown.
| Total (N = 167) | Males (N = 66) | Females (N = 101) | P values | ||
|---|---|---|---|---|---|
| Total Retina (ILM-RPE) (mean, standard deviation, range, um) | Central thickness | 200.58 (19.22, 158.4 to 264) | 204.06 (20.40, 164.2 to 264) | 198.30 (17.78, 158.4 to 263.9) | 0.07 |
| Juxtafoveal nasal | 327.14 (19.04, 267.8 to 397.1) | 329.71(19.03, 285.4 to 365.7) | 325.45 (18.95, 267.8 to 397.1) | 0.156 | |
| Juxtafoveal temporal thickness | 307.73 (17.85, 250.9 to 353.9) | 312.53 (16.55, 275.7 to 353.9) | 304.59 (18.16, 250.9 to 346.1) | 0.004 | |
| Inner Retina (ILM-OPL) (mean, standard deviation, range, um) | Central thickness | 21.47 (13.60, 0 to 78.2) | 23.52 (14.80, 0 to 78.2) | 20.13 (12.67, 0.9 to 66.5) | 0.12 |
| Juxtafoveal nasal | 201.56 (23.74, 138.8 to 287.7) | 203.40 (22.09, 158.4 to 260) | 200.36 (24.79, 138.8 to 287.7) | 0.40 | |
| Juxtafoveal temporal thickness | 174.60 (18.81, 103.6 to 234.6) | 179.62 (18.45, 138.8 to 234.6) | 171.32 (18.40, 103.6 to 219) | 0.005 | |
| Outer Retina (ONL/HFL-RPE) (mean, standard deviation, range, um) | Central thickness | 179.11 (18.52, 125.2 to 228.8) | 180.54 (18.13, 125.2 to 228.8) | 178.17 (18.78, 129.1 to 217) | 0.42 |
| Juxtafoveal nasal | 125.57 (18.43, 84to 166.2) | 126.31 (18.97, 86 to 166.2) | 125.09 (18.14, 84 to 164.2) | 0.68 | |
| Juxtafoveal temporal thickness | 133.13 (16.26, 69.1 to 172.1) | 132.91(16.46, 84.1 to 166.2) | 133.27 (16.20, 69.1 to 172.1) | 0.89 | |
| Ellipsoid zone (EZ-RPE) (mean, standard deviation, range, um) | Central thickness | 50.58 (6.01, 37.1 to 68.4) | 50.42 (6.25, 39.1 to 68.4) | 50.68 (5.879, 37.1 to 66.5) | 0.78 |
| Juxtafoveal nasal | 34.92 (5.52, 19.6 to 48.9) | 31.10 (6.04, 19.6 to 48.9) | 35.41 (5.13, 25.4 to 48.9) | 0.17 | |
| Juxtafoveal temporal thickness | 33.39 (5.47, 21.5 to 58.7) | 33.67 (5.63, 21.5 to 48.9) | 33.20 (5.39, 21.5 to 58.7) | 0.59 | |
| Area and Volumetric measurements | ONL-EZ Central Foveal Area (mm2) | 0.55 (0.05, 0.43 to 0.73) | 0.55 (0.06, 0.45 to 0.73) | 0.55 (0.05, 0.43 to 0.64) | 0.60 |
| ONL-EZ Volume (mm3) | 2.87 (0.22, 2.41 to 3.57) | 2.87 (0.24, 2.42 to 3.58) | 2.88 (0.21, 2.41 to 3.36) | 0.61 | |
| EZ-RPE Central Foveal Area (mm2) | 0.21 (0.02, 0.16 to 0.31) | 0.21 (0.03, 0.16 to 0.31) | 0.21 (0.02, 0.16 to .29) | 0.88 | |
| EZ-RPE Volume (mm3) | 1.20 (0.10, 0.97 to 1.68) | 1.2 (0.11, .97 to 1.68) | 1.2 (0.1, .99 to 1.6) | 0.76 | |
| ONL-RPE Central Foveal Area (mm2) | 0.76 (0.06, 0.63 to 0.96) | 0.77 (0.06, 0.65 to 0.96) | 0.76 (0.06, 0.62 to 0.92) | 0.58 | |
| ONL-RPE Volume (mm3) | 4.08 (0.27, 3.53 to 4.84) | 4.07 (0.27, 3.53 to 4.78) | 4.08 (0.27, 3.57 to 4.84) | 0.75 | |
| En face measurements | Twenty-micron EZ Map Coverage (%) | 0.87 (1.13, 0.01 to 4.94) | 0.99 (1.28, 0.12 to 4.93) | .78 (1.01, 0 to .62) | 0.25 |
| Zero-micron EZ Map Coverage (%) | 0.12 (0.14, 0 to 1.10) | 0.1 (0.16, 0 to 1.1) | .13 (0.13, 0 to .62) | 0.29 |
Assessment of inner and outer retinal layer metrics on the cirrus HD-OCT platform in normal eyes. Comparison to age.
| Metric | All | Males (N = 66) | Females (N = 101) | |||||
|---|---|---|---|---|---|---|---|---|
| R value | P value | R value | P value | R value | P value | |||
| Total Retina (ILM-RPE) | Central thickness | -0.07 | .34 | -0.14 | .26 | 0.01 | .94 | |
| Juxtafoveal nasal thickness | -0.14 | 0.06 | -0.19 | 0.12 | -0.09 | .34 | ||
| Juxtafoveal temporal thickness | -0.20 | 0.008 | -0.29 | 0.02 | -0.12 | .22 | ||
| Inner Retina (ILM-OPL) | Central thickness | -0.39 | 0.0000002 | -0.33 | 0.0076 | -0.43 | <0.001 | |
| Juxtafoveal nasal thickness | -0.21 | 0.006 | -0.38 | 0.36 | -0.09 | 0.36 | ||
| Juxtafoveal temporal thickness | -0.33 | 0.00001 | -0.39 | 0.0001 | -0.27 | 0.007 | ||
| Outer Retina (ONL/HFL-RPE) | Central thickness | 0.20 | 0.007 | 0.10 | 0.41 | 0.3 | 0.0024 | |
| Juxtafoveal nasal thickness | 0.12 | 0.12 | 0.25 | 0.043 | 0.03 | 0.79 | ||
| Juxtafoveal temporal thickness | 0.16 | 0.037 | 0.16 | 0.21 | 0.17 | 0.09 | ||
| Ellipsoid Zone | Central thickness | -0.06 | .43 | -0.209 | 0.09 | 0.05 | 0.60 | |
| Juxtafoveal nasal thickness | 0.10 | 0.19 | 0.04 | 0.76 | .14 | 0.16 | ||
| Juxtafoveal temporal thickness | 0.10 | 0.19 | -0.012 | 0.91 | 0.20 | 0.044 | ||
| Area and Volume measurements | ONL to EZ central foveal area | 0.16 | 0.04 | 0.23 | 0.06 | 0.1 | 0.3 | |
| ONL to EZ volume | 0.09 | 0.25 | 0.16 | 0.20 | 0.02 | 0.81 | ||
| EZ to RPE central foveal area | 0.03 | 0.64 | -0.167 | 0.18 | 0.21 | 0.03 | ||
| EZ to RPE volume | 0.05 | .52 | -0.09 | 0.46 | 0.17 | 0.07 | ||
| ONL to RPE central foveal area | 0.15 | 0.04 | 0.15 | 0.23 | 0.17 | .08 | ||
| ONL to RPE volume | 0.09 | 0.23 | 0.10 | 0.40 | 0.08 | 0.40 | ||
| En face Ellipsoid Zone mapping | Attenuation (<20 um) | -0.48 | 0.000000001 | -0.45 | 0.00013 | -0.43 | <0.001 | |
| Loss (0 micron) | 0.06 | .43 | -0.001 | 0.99 | 0.10 | 0.31 | ||
Fig 3Statistically significant retinal parameters in comparison to age.
(A) Temporal total retinal thickness showed a slightly negative correlation with age. (B) Central inner retinal thickness decreased moderately with age, while (C) nasal retinal thickness decreased slightly with age. (D) Similar to central retinal thickeness, temporal retinal thickness decreased moderately with age as well. (E) and (F) Central outer retinal thickness and temporal outer retinal thickness, respectively are both slightly negatively correlated with age. (G) and (H) ONL to EZ central foveal area and ONL to RPE central foveal area, respectively, both slightly increased with age. (I) EZ attenuation was strongly negatively correlated with age.
Assessment of inner and outer retinal layer metrics on the cirrus HD-OCT platform in normal eyes. Comparison across quartiles.
| Metric | Quartile 1 (Age 10–30) | Quartile 2 (Age 31–50) | Quartile 3 (Age 51–70) | Quartile 4 (Age 71–85) | P value | |
|---|---|---|---|---|---|---|
| Total Retina (ILM-RPE) | Central thickness | 203.38 (20.57, 166.2 to 263.9) | 201.65 (16.23, 158.4 to 230.7) | 199.16 (19.53, 161.2 to 264) | 198.156 (20.57, 164.2 to 236.5) | 0.63 |
| Juxtafoveal nasal thickness | 330.83 (19.3, 285.4 to 373.5) | 330.89 (14.93, 304.9 to 365.7) | 324.25 (20.88, 267.8 to 397.1) | 323.2 (17.78, 275.6 to 350) | 0.14 | |
| Juxtafoveal temporal thickness | 312.04 (16.78, 279.6 to 353.9) | 312.14 (13.96, 291.3 to 342.1) | 303.50 (18.28, 261.9 to 383.3) | 305.3 (21.1, 250.9 to 338.2) | 0.03 | |
| Inner Retina (ILM-OPL) | Central thickness | 29.38 (13.5, 7.8 to 62.6) | 23.79 (13.99, 3.9 to 66.5) | 17.9 (12.44, 0.9 to 78.2) | 14.5 (8.82, 0 to 41.1) | <0.001 |
| Juxtafoveal nasal thickness | 210.23 (21.52, 176 to 260) | 206.64 (20.25, 168.1 to 254.2) | 194.24 (24.59, 140.8 to 287.7) | 199.1 (24.4, 138.8 to 230.7) | 0.003 | |
| Juxtafoveal temporal thickness | 182.58 (14.84, 142.7 to 213.1) | 180.40 (21.09, 148.3 to 234.6) | 168.97 (15.77, 134.9 to 205.3) | 167.81 (21.81, 103.6 to 205.3) | <0.001 | |
| Outer Retina (ONL/HFL-RPE) | Central thickness | 174 (17.9, 129.1 to 209.2) | 177.86 (16.64, 134.9 to 205.3) | 181.28 (18.02, 125.2 to 228.8) | 183.65 (22.08, 136.9 to 220.9) | 0.13 |
| Juxtafoveal nasal thickness | 120.6 (19.47, 84 to 166.2) | 124.25 (17.47, 88 to 154.4) | 130.01 (17.7, 86 to 164.2) | 124.10 (18.33, 86 to 160.3) | 0.07 | |
| Juxtafoveal temporal thickness | 129.46 (11.38, 103.6 to 150.5) | 131.73 (16.63, 84.1 to 162.2) | 134.53 (16.95, 99.7 to 172.1) | 137.50 (19.78, 69.1 to 166.2) | 0.2 | |
| Ellipsoid Zone | Central thickness | 50.22 (6.44, 41.1 to 62.6) | 52.46 (6.26, 43 to 68.4) | 50.38 (5.89, 37.1 to 66.5) | 49.0 (4.75, 39.1 to 58.7) | 0.14 |
| Juxtafoveal nasal thickness | 33.80 (6.63, 19.6 to 48.9) | 35.29 (5.10, 25.4 to 46.9) | 35.48 (5.02, 27.4 to 46.9) | 34.8 (5.4, 25.4 to 48.9) | 0.48 | |
| Juxtafoveal temporal thickness | 32.32 (5.52, 23.5 to 48.9) | 33.61 (6.0, 21.5 to 48.9) | 33.89 (5.57, 21.5 to 58.7) | 33.54 (4.32, 25.4 to 43) | 0.54 | |
| Area and Volume measurements | ONL to EZ central foveal area | 0.54 (0.05, 0.43 to 0.63) | 0.54 (0.04, 0.45 to 0.63) | 0.56 (0.06, 0.455 to 0.73) | 0.56 (0.04, 0.46 to 0.63) | 0.10 |
| ONL to EZ volume | 2.84 (0.2, 2.42 to 3.36) | 2.86 (0.20, 2.45 to 26) | 2.89 (0.27 (2.4 to 3.58) | 2.91 (0.16, 2.54 to 3.17) | 0.55 | |
| EZ to RPE central foveal area | 0.20 (0.03, 0.16 to 0.31) | 0.21 (0.02, 0.16 to 0.28) | 0.21 (0.02, 0.16 to 0.3) | 0.21 (0.01, 0.17 to 0.23) | 0.70 | |
| EZ to RPE volume | 1.20 (0.14, 1.0 to 1.68) | 1.19 (0.09, 1.04 to 1.38) | 1.21 (0.10, 0.98 to 1.6) | 1.19 (0.07, 0.96 to 1.31) | 0.65 | |
| ONL to RPE central foveal area | 0.75 (0.05, 0.62 to 0.87) | 0.75 (0.05, 0.6 to 0.86) | 0.77 (0.06, 0.65 to 0.96) | 0.77 (0.04, 0.67 to 0.84) | 0.09 | |
| ONL to RPE volume | 4.04 (0.25, 3.6 to 4.84) | 4.05 (0.26, 3.6 to 4.65) | 4.10 (0.31, 3.53 to 4.8) | 4.11 (0.19, 3.66 to 4.40) | 0.55 | |
| En face Ellipsoid Zone mapping | Attenuation (20 um) | 1.58 (1.44, 0.04 to 4.93) | 1.08 (1.29, 0.018 to 4.67) | 0.44 (0.65, 0.01 to 3.8) | 0.47 (0.47, 0.01 to 1.71) | <0.001 |
| Loss (0 um) | 0.10 (0.11, 0 to 0.42) | 0.13 (0.21, 0 to 28) | 0.12 (0.12, 0 to 0.62) | 0.13 (0.12, 0 to 0.41) | 0.75 |